Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Drugs for Short Bowel Syndrome market report explains the definition, types, applications, major countries, and major players of the Drugs for Short Bowel Syndrome market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Shire
Sancilio & Company
Nutrinia
Naia Pharmaceuticals
GLyPharma Therapeutic
Zealand Pharma
OxThera
Ardelyx
Merck
Emmaus Life Sciences
By Type:
GLP-2
Growth Hormone
Glutamine
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Drugs for Short Bowel Syndrome Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Drugs for Short Bowel Syndrome Outlook to 2028- Original Forecasts
-
2.2 Drugs for Short Bowel Syndrome Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Drugs for Short Bowel Syndrome Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Drugs for Short Bowel Syndrome Market- Recent Developments
-
6.1 Drugs for Short Bowel Syndrome Market News and Developments
-
6.2 Drugs for Short Bowel Syndrome Market Deals Landscape
7 Drugs for Short Bowel Syndrome Raw Materials and Cost Structure Analysis
-
7.1 Drugs for Short Bowel Syndrome Key Raw Materials
-
7.2 Drugs for Short Bowel Syndrome Price Trend of Key Raw Materials
-
7.3 Drugs for Short Bowel Syndrome Key Suppliers of Raw Materials
-
7.4 Drugs for Short Bowel Syndrome Market Concentration Rate of Raw Materials
-
7.5 Drugs for Short Bowel Syndrome Cost Structure Analysis
-
7.5.1 Drugs for Short Bowel Syndrome Raw Materials Analysis
-
7.5.2 Drugs for Short Bowel Syndrome Labor Cost Analysis
-
7.5.3 Drugs for Short Bowel Syndrome Manufacturing Expenses Analysis
8 Global Drugs for Short Bowel Syndrome Import and Export Analysis (Top 10 Countries)
-
8.1 Global Drugs for Short Bowel Syndrome Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Drugs for Short Bowel Syndrome Export by Region (Top 10 Countries) (2017-2028)
9 Global Drugs for Short Bowel Syndrome Market Outlook by Types and Applications to 2022
-
9.1 Global Drugs for Short Bowel Syndrome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GLP-2 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glutamine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Drugs for Short Bowel Syndrome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Drugs for Short Bowel Syndrome Market Analysis and Outlook till 2022
-
10.1 Global Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.2.2 Canada Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.2.3 Mexico Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.2 UK Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.3 Spain Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.4 Belgium Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.5 France Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.6 Italy Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.7 Denmark Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.8 Finland Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.9 Norway Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.10 Sweden Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.11 Poland Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.12 Russia Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.3.13 Turkey Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.2 Japan Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.3 India Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.4 South Korea Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.5 Pakistan Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.6 Bangladesh Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.7 Indonesia Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.8 Thailand Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.9 Singapore Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.10 Malaysia Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.11 Philippines Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.4.12 Vietnam Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.5.2 Colombia Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.5.3 Chile Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.5.4 Argentina Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.5.5 Venezuela Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.5.6 Peru Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.5.7 Puerto Rico Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.5.8 Ecuador Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.6.2 Kuwait Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.6.3 Oman Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.6.4 Qatar Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.6.5 Saudi Arabia Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.6.6 United Arab Emirates Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.7.2 South Africa Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.7.3 Egypt Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.7.4 Algeria Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
10.8.2 New Zealand Drugs for Short Bowel Syndrome Consumption (2017-2022)
11 Global Drugs for Short Bowel Syndrome Competitive Analysis
-
11.1 Shire
-
11.1.1 Shire Company Details
-
11.1.2 Shire Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Shire Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.1.4 Shire Drugs for Short Bowel Syndrome Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Sancilio & Company
-
11.2.1 Sancilio & Company Company Details
-
11.2.2 Sancilio & Company Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Sancilio & Company Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.2.4 Sancilio & Company Drugs for Short Bowel Syndrome Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Nutrinia
-
11.3.1 Nutrinia Company Details
-
11.3.2 Nutrinia Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Nutrinia Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.3.4 Nutrinia Drugs for Short Bowel Syndrome Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Naia Pharmaceuticals
-
11.4.1 Naia Pharmaceuticals Company Details
-
11.4.2 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.4.4 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 GLyPharma Therapeutic
-
11.5.1 GLyPharma Therapeutic Company Details
-
11.5.2 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.5.4 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Zealand Pharma
-
11.6.1 Zealand Pharma Company Details
-
11.6.2 Zealand Pharma Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Zealand Pharma Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.6.4 Zealand Pharma Drugs for Short Bowel Syndrome Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 OxThera
-
11.7.1 OxThera Company Details
-
11.7.2 OxThera Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 OxThera Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.7.4 OxThera Drugs for Short Bowel Syndrome Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Ardelyx
-
11.8.1 Ardelyx Company Details
-
11.8.2 Ardelyx Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Ardelyx Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.8.4 Ardelyx Drugs for Short Bowel Syndrome Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Merck
-
11.9.1 Merck Company Details
-
11.9.2 Merck Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Merck Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.9.4 Merck Drugs for Short Bowel Syndrome Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Emmaus Life Sciences
-
11.10.1 Emmaus Life Sciences Company Details
-
11.10.2 Emmaus Life Sciences Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Main Business and Markets Served
-
11.10.4 Emmaus Life Sciences Drugs for Short Bowel Syndrome Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Drugs for Short Bowel Syndrome Market Outlook by Types and Applications to 2028
-
12.1 Global Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global GLP-2 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Drugs for Short Bowel Syndrome Market Analysis and Outlook to 2028
-
13.1 Global Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.2.2 Canada Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.2.3 Mexico Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.2 UK Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.3 Spain Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.4 Belgium Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.5 France Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.6 Italy Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.7 Denmark Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.8 Finland Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.9 Norway Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.10 Sweden Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.11 Poland Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.12 Russia Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.3.13 Turkey Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.2 Japan Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.3 India Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.4 South Korea Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.8 Thailand Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.9 Singapore Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.11 Philippines Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.2 Colombia Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.3 Chile Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.4 Argentina Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.6 Peru Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.3 Oman Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.4 Qatar Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.7.2 South Africa Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.7.3 Egypt Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.7.4 Algeria Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Drugs for Short Bowel Syndrome
-
Figure of Drugs for Short Bowel Syndrome Picture
-
Table Global Drugs for Short Bowel Syndrome Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Drugs for Short Bowel Syndrome Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global GLP-2 Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Table North America Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure United States Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Canada Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Mexico Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Europe Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Germany Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure UK Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Spain Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Belgium Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure France Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Italy Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Denmark Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Finland Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Norway Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Sweden Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Poland Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Russia Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Turkey Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table APAC Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure China Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Japan Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure India Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Thailand Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Singapore Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Philippines Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table South America Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Brazil Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Colombia Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Chile Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Argentina Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Peru Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table GCC Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Bahrain Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Oman Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Qatar Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Africa Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Nigeria Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Africa Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Egypt Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Algeria Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Oceania Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure Australia Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Shire Company Details
-
Table Shire Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table Shire Drugs for Short Bowel Syndrome Product Portfolio
-
Table Sancilio & Company Company Details
-
Table Sancilio & Company Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sancilio & Company Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table Sancilio & Company Drugs for Short Bowel Syndrome Product Portfolio
-
Table Nutrinia Company Details
-
Table Nutrinia Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nutrinia Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table Nutrinia Drugs for Short Bowel Syndrome Product Portfolio
-
Table Naia Pharmaceuticals Company Details
-
Table Naia Pharmaceuticals Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Naia Pharmaceuticals Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product Portfolio
-
Table GLyPharma Therapeutic Company Details
-
Table GLyPharma Therapeutic Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table GLyPharma Therapeutic Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product Portfolio
-
Table Zealand Pharma Company Details
-
Table Zealand Pharma Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zealand Pharma Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table Zealand Pharma Drugs for Short Bowel Syndrome Product Portfolio
-
Table OxThera Company Details
-
Table OxThera Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table OxThera Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table OxThera Drugs for Short Bowel Syndrome Product Portfolio
-
Table Ardelyx Company Details
-
Table Ardelyx Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ardelyx Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table Ardelyx Drugs for Short Bowel Syndrome Product Portfolio
-
Table Merck Company Details
-
Table Merck Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table Merck Drugs for Short Bowel Syndrome Product Portfolio
-
Table Emmaus Life Sciences Company Details
-
Table Emmaus Life Sciences Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emmaus Life Sciences Drugs for Short Bowel Syndrome Main Business and Markets Served
-
Table Emmaus Life Sciences Drugs for Short Bowel Syndrome Product Portfolio
-
Figure Global GLP-2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Table North America Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure United States Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Germany Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure China Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Brazil Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure Australia Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
